Nonabsorbable Corticosteroids Use in the Treatment of Gastrointestinal Graft-versus-Host Disease
Open Access
- 1 April 2009
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 15 (4) , 395-405
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host diseaseBlood, 2008
- Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantationExpert Opinion on Investigational Drugs, 2007
- Pathophysiology of acute graft-versus-host disease: recent advancesTranslational Research, 2007
- Use of Proton Pump Inhibitors and the Risk of Community-Acquired PneumoniaArchives of internal medicine (1960), 2007
- Unrelated donor bone marrow transplantation for β-thalassemia major: an experience from ChinaBone Marrow Transplantation, 2005
- Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal CancerOncology, 2005
- Long-Term Use of Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2005
- Gastric Bleeding Due to Graft-vs-Host DiseaseAmerican Journal of Clinical Pathology, 2004
- Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive DrugsJAMA, 2004
- Pharmacokinetics of Budesonide (Entocort??? EC) Capsules for Crohn???s DiseaseClinical Pharmacokinetics, 2004